The Nuclear Medicine Pilot Research Grant in Neuroendocrine Tumors (NETs)
This grant funds early-career scientists for innovative nuclear medicine research on neuroendocrine tumors, with a focus on translational radionuclide imaging or therapy studies.
Funder: Education and Research Foundation for Nuclear Medicine and Molecular Imaging
Due Dates: August 31, 2026
Funding Amounts: $100,000 total over two years; second year contingent on progress; indirect costs capped at 5%
Summary: Supports early-career scientists undertaking innovative nuclear medicine research on neuroendocrine tumors to generate preliminary data for future larger-scale funding.
Description
This grant aims to empower early-career basic or clinical scientists to conduct novel, high-impact research in nuclear medicine focused on neuroendocrine tumors (NETs). The initiative is designed to help researchers generate essential preliminary data and demonstrate the feasibility of innovative ideas, specifically in translational in vivo studies involving radionuclide imaging or therapy. The award is sponsored by the Neuroendocrine Tumor Research Foundation (NETRF) and emphasizes original, non-incremental research that advances molecular imaging and therapy for NETs. Recipients are required to submit regular progress reports and present their findings at the annual NETRF Research Symposium.
